Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L6PL
|
|||
Former ID |
DNC007533
|
|||
Drug Name |
3-biphenyl-4-ylethynyl-5-methyl-[1,2,4]triazine
|
|||
Synonyms |
CHEMBL226831; 3-biphenyl-4-ylethynyl-5-methyl-[1,2,4]triazine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H13N3
|
|||
Canonical SMILES |
CC1=CN=NC(=N1)C#CC2=CC=C(C=C2)C3=CC=CC=C3
|
|||
InChI |
1S/C18H13N3/c1-14-13-19-21-18(20-14)12-9-15-7-10-17(11-8-15)16-5-3-2-4-6-16/h2-8,10-11,13H,1H3
|
|||
InChIKey |
OXVAGVMMJCNKRK-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and pharmacological evaluation of phenylethynyl[1,2,4]methyltriazines as analogues of 3-methyl-6-(phenylethynyl)pyridine. J Med Chem. 2007 Jul 12;50(14):3388-91. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.